收藏切换
Effectiveness and safety of anlotinib combined with hyperthermia chemotherapy in the second-line treatment of patients with extensive-stage small cell lung cancer
收藏切换
Weiwei WANG, Daqing WANG, Shuangqing CAO*
World Clinical Drug | 2022, 43(9) : 1130 - 1137
Less
收藏切换
World Clinical Drug | 2022, 43(9): 1130-1137
• Article •
Effectiveness and safety of anlotinib combined with hyperthermia chemotherapy in the second-line treatment of patients with extensive-stage small cell lung cancer
Full
Weiwei WANG, Daqing WANG, Shuangqing CAO*
Affiliations
  • Department of Oncology, Harrison Internatioanal Peace Hospital, Hengshui 053000, Hebei Province, China
Published: 2022-09-10 doi: 10.13683/j.wph.2022.09.009
Outline
收藏切换
Objective

To investigate the effectiveness and safety of anlotinib combined with hyperthermia chemotherapy in the second-line treatment of patients with extensive-stage small cell lung cancer (ES-SCLC).

Methods

A total of 40 patients with ES-SCLC who had relapsed after the first-line treatment admitted to Harrison international peace hospital from February 2020 to June 2022 were selected and randomly divided into the observation group and control group, 20 cases in each group. The patients in the control group received hyperthermia chemotherapy with irinotecan and the patients in the observation group were treated with anlotinib based on the control group (took it for 2 weeks and stopped for 1 week). Every 3 weeks was a cycle. The efficacy and adverse reactions of the two groups were compared.

Results

After 2 cycles of chemotherapy, total effective rate for solid tumors, disease control rate of tumors, progression-free survival (PFS) and overall survival (OS) of the observation group were higher than those of the control group (P<0.05). The serum levels of carcinoembryonic antigen, carbohydrate antigen 125, cytokeratin 19 fragment antigen 21-1, pro-gastrin-releasing peptide, neuron-specific enolase of the observation group were higher than those of the control group (P<0.05). There was no significant difference in the occurrence of adverse reactions between the two groups during chemotherapy (P>0.05). The serum levels of vascular endothelial growth factor and angiopoietin-2 of the observation group were higher than those of the control group (P<0.05).

Conclusion

Anlotinib combined with hyperthermia chemotherapy in the second-line treatment of patients with ES-SCLC can improve the short-term efficacy, reduce the level of serum tumor markers, inhibit tumor angiogenesis, prolong PFS and OS, and it is safe and reliable.

anlotinib  /  hyperthermia chemotherapy  /  extensive-stage small cell lung cancer  /  second-line trestment  /  clinical efficacy  /  safety
王薇薇, 王大庆, 曹双清. 安罗替尼联合热化疗用于广泛期小细胞肺癌二线治疗的有效性及安全性. 世界临床药物, 2022 , 43 (9) : 1130 -1137 . DOI: 10.13683/j.wph.2022.09.009
Weiwei WANG, Daqing WANG, Shuangqing CAO. Effectiveness and safety of anlotinib combined with hyperthermia chemotherapy in the second-line treatment of patients with extensive-stage small cell lung cancer[J]. World Clinical Drug, 2022 , 43 (9) : 1130 -1137 . DOI: 10.13683/j.wph.2022.09.009
Year 2022 volume 43 Issue 9
6
0
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.09.009
  • Receive Date:2021-12-13
  • Online Date:2026-11-19
  • Published:2022-09-10
Article Data
Affiliations
History
  • Received:2021-12-13
  • Revised:2022-08-04
Funding
Affiliations
    Department of Oncology, Harrison Internatioanal Peace Hospital, Hengshui 053000, Hebei Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.09.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT